Drug intelligence / Profile preview

ciprofloxacin + amoxicillin

Development stage
Preclinical
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Ciprofloxacin + amoxicillin is a combination of two antibiotics, each with distinct mechanisms of action. Ciprofloxacin is a second-generation fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination. Amoxicillin is a penicillin-type beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. This combination has been studied for its antibacterial effects against various pathogens, including beta-lactamase-producing Staphylococcus aureus. The interaction between these drugs can be additive or synergistic depending on the ratio used; however, certain ratios may result in antagonism[2][5]. Both drugs are widely used individually for the treatment of respiratory tract infections, urinary tract infections, skin infections, and other susceptible bacterial diseases[3][6].

02

Targets

DNA gyrasePBP (Penicillin-binding protein family)Topo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on ciprofloxacin + amoxicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciprofloxacin + amoxicillin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call